US rejects Orexigen diet drug over heart risks
By Lewis Krauskopf NEW YORK, Feb 1 (Reuters) – US health regulators rejected Orexigen Therapeutics Inc's (OREX.O) weight–loss drug and requested a clinical …
See all stories on this topic »
Good Health is Your Greatest Wealth……Virgil
By Lewis Krauskopf NEW YORK, Feb 1 (Reuters) – US health regulators rejected Orexigen Therapeutics Inc's (OREX.O) weight–loss drug and requested a clinical …
See all stories on this topic »